Abstract
No public abstract is available from the verified source records.
Chaimae Nouri, Latifa Tahiri, Hanan Rkain, Fatine Kronbi, Fadoua Allali
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
10.1136/ard-2022-223356 · 2023
Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases
10.1097/md.0b013e3181441a68 · 2007
Vasculitis associated with tumor necrosis factor-α inhibitors
10.1016/j.mayocp.2012.04.011 · 2012
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
10.1002/art.1780380107 · 1995
Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France
10.1016/j.jbspin.2006.02.010 · 2006
Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents
2004
Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database
10.1080/00325481.2026.2696097 · 2026
A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis
10.1007/s40257-014-0076-6 · 2014
Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force
10.1111/jdv.70249 · 2026
Leukocytoclastic vasculitis due to etanercept
2000
Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis
10.5414/cnp62234 · 2004
Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis
10.1093/ndt/gfh832 · 2005
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
10.1002/art.37715 · 2013
Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
10.1002/art.40375 · 2018
Drug-induced cutaneous vasculitides
2015
Vasculitis associated with rheumatoid arthritis: a case-control study
10.1093/rheumatology/ket475 · 2014
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study
10.3109/03009742.2014.923931 · 2015
Cryoglobulinemic vasculitis in primary Sjögren's syndrome: clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease
10.1016/j.semarthrit.2020.07.013 · 2020
Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients
10.1007/s10875-008-9214-3 · 2008
Management of cutaneous vasculitis
10.1016/j.lpm.2020.104033 · 2020
No additional external references are available.